Publications

 
 
 
 
 

Showing 1036-1050 from 1626 publications.

  • Goldenberg I, Subirana I, Boyko V, Vila J, Elosua R, Permanyer-Miralda G, Ferreira-González I, Benderly M, Guetta V, Behar S, Marrugat J. Relation between renal function and outcomes in patients with non-ST-segment elevation acute coronary syndrome: real-world data from the European Public Health Outcome Research and Indicators Collection Project. Arch. Intern. Med. 2010 May; 170(10): 888-95

    IF: 9.11, Quartile: 1, Decile: 1

    View abstract

  • Gomis M, Ois A, Rodríguez-Campello A, Cuadrado-Godia E, Jiménez-Conde J, Subirana I, Dávalos A, Roquer J. Outcome of intracerebral haemorrhage patients pre-treated with statins. Eur. J. Neurol. 2010 Mar; 17(3): 443-8

    IF: 2.732, Quartile: 2

    View abstract

  • Grau M, Subirana I, Elosua R, Fitó M, Covas MI, Sala J, Masiá R, Ramos R, Solanas P, Cordón F, Nieto FJ, Marrugat J. Why should population attributable fractions be periodically recalculated? An example from cardiovascular risk estimation in southern Europe. Prev Med 2010 Jul; 51(1): 78-84

    IF: 3.299, Quartile: 1

    View abstract

  • Sanchis J, Bosch X, Bodí V, Núñez J, Doltra A, Heras M, Mainar L, Santas E, Bragulat E, Garcia-Alvarez A, Carratalá A, Llàcer A. Randomized comparison between clinical evaluation plus N-terminal pro-B-type natriuretic peptide versus exercise testing for decision making in acute chest pain of uncertain origin. Am. Heart J. 2010 Feb; 159(2): 176-82

    IF: 4.285, Quartile: 1

    View abstract

  • Grau M, Bongard V, Fitó M, Ruidavets JB, Sala J, Taraszkiewicz D, Masiá R, Galinier M, Subirana I, Carrié D, Vila J, Marrugat J, Ferrières J. Prevalence of cardiovascular risk factors in men with stable coronary heart disease in France and Spain. Arch Cardiovasc Dis 2010 Feb; 103(2): 80-9

    IF: 1.209

    View abstract

  • Romero M, Jimenez R, Hurtado B, Moreno JM, Rodríguez-Gómez I, López-Sepúlveda R, Zarzuelo A, Perez-Vizcaino F, Tamargo J, Vargas F, Duarte J. Lack of beneficial metabolic effects of quercetin in adult spontaneously hypertensive rats. Eur. J. Pharmacol. 2010 Feb; 627(1): 242-50

    IF: 2.787, Quartile: 2

    View abstract

  • Jimenez R, Sánchez M, Zarzuelo MJ, Romero M, Quintela AM, López-Sepúlveda R, Galindo P, Gómez-Guzmán M, Haro JM, Zarzuelo A, Perez-Vizcaino F, Duarte J. Endothelium-dependent vasodilator effects of peroxisome proliferator-activated receptor beta agonists via the phosphatidyl-inositol-3 kinase-Akt pathway. J. Pharmacol. Exp. Ther. 2010 Feb; 332(2): 554-61

    IF: 4.309, Quartile: 1

    View abstract

  • Amorós I, Barana A, Caballero R, Gómez R, Osuna L, Lillo MP, Tamargo J, Delpón E. Endocannabinoids and cannabinoid analogues block human cardiac Kv4.3 channels in a receptor-independent manner. J. Mol. Cell. Cardiol. 2010 Jan; 48(1): 201-10

    IF: 5.054, Quartile: 1

    View abstract

  • Barana A, Amorós I, Caballero R, Gómez R, Osuna L, Lillo MP, Blázquez C, Guzmán M, Delpón E, Tamargo J. Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner. Cardiovasc. Res. 2010 Jan; 85(1): 56-67

    IF: 5.947, Quartile: 1, Decile: 1

    View abstract

  • Marques M, Sacristán D, Mateos-Cáceres PJ, Herrero J, Arribas MJ, González-Armengol JJ, Villegas A, Macaya C, Barrientos A, López-Farré AJ. Different protein expression in normal and dysfunctional platelets from uremic patients. J. Nephrol. 2010; 23(1): 90-101

    IF: 1.211, Quartile: 4

    View abstract

  • Mateos-Cáceres PJ, Macaya C, Azcona L, Modrego J, Mahillo E, Bernardo E, Fernández-Ortiz A, López-Farré AJ. Different expression of proteins in platelets from aspirin-resistant and aspirin-sensitive patients. Thromb. Haemost. 2010 Jan; 103(1): 160-70

    IF: 3.803, Quartile: 1

    View abstract

  • Modrego J, Maroto L, Tamargo J, Azcona L, Mateos-Cáceres P, Segura A, Moreno-Herrero R, Perez-Castellanos N, Delpón E, Pérez-Villacastín J, Rodríguez E, Macaya C, López-Farré AJ. Comparative expression of proteins in left and right atrial appendages from patients with mitral valve disease at sinus rhythm and atrial fibrillation. J. Cardiovasc. Electrophysiol. 2010 Aug; 21(8): 859-68

    IF: 3.798, Quartile: 1

    View abstract

  • Zamorano-León JJ, Modrego J, Mateos-Cáceres PJ, Macaya C, Martín-Fernández B, Miana M, de las Heras N, Cachofeiro V, Lahera V, López-Farré AJ. A proteomic approach to determine changes in proteins involved in the myocardial metabolism in left ventricles of spontaneously hypertensive rats. Cell. Physiol. Biochem. 2010; 25(2): 347-58

    IF: 3.246, Quartile: 2

    View abstract

  • Garcia-Alvarez A, Arzamendi D, Loma-Osorio P, Kiamco R, Masotti M, Sionis A, Betriu A, Brugada J, Bosch X. Early risk stratification of patients with cardiogenic shock complicating acute myocardial infarction who undergo percutaneous coronary intervention. Am. J. Cardiol. 2009 Apr; 103(8): 1073-7

    IF: 3.905, Quartile: 1

    View abstract

  • de las Heras N, Martín-Fernández B, Miana M, Ballesteros S, Oubiña MP, López-Farré AJ, Cachofeiro V, Lahera V. The protective effect of irbesartan in rats fed a high fat diet is associated with modification of leptin-adiponectin imbalance. J Hypertens Suppl 2009 Aug; 27(6): S37-41

    IF: 4.988, Quartile: 1

    View abstract

An initiative of

Ministerio de Economía y Competitividad Fondo Europeo de Desarrollo Regional IMIM - Parc de Salut Mar